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Abstract
Background: Disc degeneration (DD) is a common condition that progresses with aging. Although the events
leading to DD are not well understood, a significant genetic influence has been found. This study was undertaken
to assess the association between relevant candidate gene polymorphisms and moderate DD in a well-defined and
characterized cohort of young adults. Focusing on young age can be valuable in determining genetic
predisposition to DD.
Methods: We investigated the associations of existing candidate genes for DD among 538 young adults with a
mean age of 19 belonging to the 1986 Northern Finland Birth Cohort. Nineteen single nucleotide polymorphisms
(SNP) in 16 genes were genotyped. We evaluated lumbar DD using the modified Pfirrmann classification and a 1.5-
T magnetic resonance scanner for imaging.
Results: Of the 538 individuals studied, 46% had no degeneration, while 54% had DD and 51% of these had
moderate DD. The risk of DD was significantly higher in subjects with an allele G of IL6 SNPs rs1800795 (OR 1.45,
95% CI 1.07-1.96) and rs1800797 (OR 1.37, 95% CI 1.02-1.85) in the additive inheritance model. The role of IL6 was
further supported by the haplotype analysis, which resulted in an association between the GGG haplotype (SNPs
rs1800797, rs1800796 and rs1800795) and DD with an OR of 1.51 (95% CI 1.11-2.04). In addition, we observed an
association between DD and two other polymorphisms, SKT rs16924573 (OR 0.27 95% CI 0.07-0.96) and CILP
rs2073711 in women (OR 2.04, 95% CI 1.07-3.89).
Conclusion: Our results indicate that IL6, SKT and CILP are involved in the etiology of DD among young adults.
Background
Disc degeneration (DD) is a multifactorial condition that
progresses with aging. With age, histological, metabolic
and functional changes take place in the disc, making it
stiffer and reducing its strength [1]. Although the events
leading to DD are not well understood, the outcome of
studies over the last decade has shown that genetic
influence plays a large role in DD, together with envir-
onmental factors [2]. Known environmental risk factors
for DD include body mass index (BMI) and heavy
physical loading [3], although their effect is weak in
comparison to heredity [4].
To date, several gene loci associated with human disc
degeneration have been identified [5]. Variations in the
genes involved in inflammation, extracellular matrix
components, and protein metabolism have been
reported as associating with DD [6,7]. The first poly-
morphisms associated with DD were two variations in
the Vitamin D receptor gene (TaqI and FokI) [8]. Subse-
quently, associations with aggrecan (ACAN)a n dt w o
collagen IX genes (COL9A2, COL9A3) were reported
[9-11]. The structural components of the intervertebral
disc have been an obvious choice as candidate genes,
because variations in structural genes may render discs
more vulnerable to mechanical loading, causing injuries
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disc function [5]. In addition, variants in genes encoding
cytokines, such as interleukin-1 (IL1)a n di n t e r l e u k i n - 6
(IL6), or degradative metalloproteinases (MMPs) have
been reported as being associated with DD [12-15]. The
genes of adipocytokines are also putative candidates for
DD due to the association between DD and athero-
sclerosis [16]. However, of the reported associations,
only a few have been verified in different ethnic popula-
tions [2].
Although genetic analyses have gained a more central
role in the exploration of the underlying causes of DD,
its etiology and pathogenesis still remain unclear. In
general, genetic studies have suffered from small sample
sizes and differences in the definition and characteriza-
tion of DD. Here we investigated the association
between relevant candidate gene polymorphisms and
moderate DD in a well-defined and characterized cohort
of young adults. Focusing on moderate DD phenotype
manifesting at an early age will provide a better oppor-
tunity to determine the predisposing role of genetic
polymorphisms.
Methods
Study population
The study population consisted of members of the 1986
Northern Finland Birth Cohort (NFBC 1986) with an
expected date of birth between July 1, 1985 and June 30,
1986 (n = 9479) in the two northernmost provinces of
Finland; Oulu and Lapland. The 2969 that lived within
100 km of the city of Oulu received a postal question-
naire in 2003. Altogether, 1987 responded, with a mean
age of 18 (response rate 68%) and were invited to parti-
cipate in a physical examination, which took place in
2005-2006 at a mean age of 19. The participants of the
examination (n = 874) were invited to participate in
lumbar spine magnetic resonance imaging (MRI) [17].
Our study population consisted of 538 subjects with
both DNA sample and lumbar spine MRI. The Ethics
Committee of the Northern Ostrobothnia Hospital Dis-
trict approved the study plan, and the study was per-
formed according to the Declaration of Helsinki.
Written informed consent was obtained from all
individuals.
Magnetic resonance imaging
MRI scans were performed using a 1.5-T unit (Signa,
General Electric, Milwaukee, WI) and phased array
spine coil (USA Instruments, Aurora OH, USA) with
the imaging protocol of a sagittal T1-weighted (440/14
[repetition time msec/echo time msec]) spin echo, a
sagittal T2-weighted (3960/116) fast spin echo (FSE),
and the axial T2-weighted FSE (5160/107) of the entire
lumbar spine.
The degree of DD was graded from T2-weighted
images using a modified Pfirrmann classification: Grade
1 (normal shape, no horizontal bands, distinction of
nucleus, and annulus is clear), Grade 2 (nonhomoge-
neous shape with horizontal bands, some blurring
between nucleus and anulus), Grade 3 (nonhomoge-
neous shape with blurring between nucleus and anulus,
anulus shape still recognizable), Grade 4 (nonhomoge-
neous shape with hypointensity, anulus shape not intact
and distinction between nucleus and anulus impossible,
disc height usually decreased), and Grade 5 (same as
Grade 4 but collapsed disc space) [17,18]. In the modi-
fied Pfirrmann classification, hyperintensity or isointen-
sity of the intervertebral disc to cerebrospinal fluid
(CSF) ratios were not used as criteria for Grades 1
through 3, due to the fact that CSF was hyperintense
compared to the discs in all the MR sequences. Moder-
ate DD was defined as Grade 4 degeneration at one or
more lumbar levels, or Grade 3 degeneration at three or
more levels. Subjects with Grade 1 and Grade 2 findings
and no other pathology in MRI were defined as the
reference group, i.e. subjects without DD. Information
on inter-rater reliability and comparison of the MRI
study population and the rest of the survey respondents
have been published elsewhere [17].
Candidate gene and single-nucleotide polymorphism
(SNP) selection
A tt h et i m eo ft h es t u d yc o n c e p t i o nw el i s t e da l lp u t a -
tive DD candidate genes and polymorphisms. The cur-
rent genotyping assay of choice is designed for SNP
genotyping thus excluding other types of genetic varia-
tions from this study. After testing different polymerase
chain reaction (PCR) multiplexes we were able to
include nineteen SNPs in five separate multiplexes.
These SNPs were distributed in 16 different genes
(Table 1). Due to the structure of the DNA sequences
at the SNP sites we were not able to include all possible
polymorphisms in the analyses. Four genes with concei-
vable relevant biological importance and/or preliminary
association in other populations (unpublished results) to
the phenotype in question were included in the study
(ADIPOQ: rs2241766, COL22A1:rs2292927, LEPR:
rs1137100 and rs8179183, and MMP10:rs470154).
SNP genotyping
We isolated DNA from frozen whole blood and per-
formed the genotyping using a single base extension
fluorescent method, the SNaPshot Multiplex Kit
(Applied Biosystems). PCR amplification and SNaPshot
extension reactions were both designed to have the
same annealing temperature. The SAP/ExoI purified
PCR product was processed according to the manufac-
turer’s protocol with the exception of the halved amount
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out analysis using the ABI3031xl Genetic Analyzer
(Applied Biosystems), and determined the genotypes
using GeneMapper software (Applied Biosystems). We
validated the genotype results from a randomly chosen
10% of samples for each SNP by direct sequencing,
using the abovementioned genetic analyzer with BigDye
chemistry from the same manufacturer. Genotyping was
blinded towards MRI status.
Statistical Analysis
We tested the potential deviation from the Hardy-Wein-
berg equilibrium (HWE) using the chi-square test. Prior
to polymorphism association, the possible effect of gen-
der, BMI and height on the DD status was analyzed
using the SAS program (V 9.2). Crude and adjusted ORs
and their 95% confidence intervals (CIs) were calculated
using logistic regression with SAS. The dependent vari-
able was DD phenotype and independent variables were
genotype, allele or haplotype. Haplotypes were first esti-
mated by SNPStats [19] and then statistically recon-
structed from population genotype data, using the
PHASE program and the Markov-chain method for hap-
lotype assignments [20]. In candidate gene association
s t u d i e s ,t h eq u e s t i o n sa r em o r es p e c i f i ct h a ni nw h o l e
genome association studies. Therefore, in the setting of
existing a priori hypotheses, multiple testing corrections
were only accounted for in genes with multiple SNPs.
The Bonferroni-Holm method was used for multiple
testing corrections [21].
Results
Clinical results
Of the 538 subjects in this study, 45.7% (N = 246) did
not have DD, whereas 54.3% (N = 292) had DD. Of the
292 individuals with DD, 51.4% (N = 150) had moderate
DD as defined in the method section. The remaining
142 individuals had degenerative findings but were not
included in the analysis. Height and BMI were asso-
ciated with DD (Table 2), but after adjustment for
height, BMI was no longer associated with DD. DD was
more frequent among men (32.1%) than women (24.9%),
but the difference was not statistically significant when
adjusted for height.
Genetic associations
Overall, genotyping of all the subjects from the selected
19 SNPs was 98% successful. All the genotype frequen-
cies analyzed were in HWE. Associations were observed
in three of the 16 genes tested. Table 3 presents the
genotype frequencies and respective ORs for individual
SNP. The strongest associations with DD were observed
for polymorphisms in IL6 (Table 3). The IL6 rs1800795
G-allele was associated with the degenerative phenotype
in an additive manner; GC-genotype, OR 1.51 [0.92-
2.47] and GG-genotype, OR 2.09 [1.14-3.85]. Minor
allele (G) frequencies were 0.490 and 0.398 in subjects
with and without DD, respectively (OR 1.45 [1.07-1.96]).
The rs1800797 was similarly associated with the DD
phenotype, suggesting an additive model (GA: OR 1.55
[0.95-2.54]), GG: OR 1.85 [1.01-3.39]), compared to the
AA-genotype. G-allele frequencies were 0.490 and 0.409
among subjects with and without DD, respectively (OR
1.37 [1.02-1.85]). Subsequent haplotype analyses resulted
in an association between the GGG haplotype (from
rs1800797, rs1800796 and rs1800795, respectively) and
DD (OR 1.48 [1.09-2.01]) (Table 4). From this haplo-
type, only one SNP (rs1800796) did not individually
associate with DD. The effect of the GGG haplotype
was additive, while the most frequent haplotype irre-
spective of the MRI findings was AGC.
The GA genotype of the SKT (KIAA1217) polymorph-
ism rs16924573 was associated with a reduced risk of DD
(OR 0.27 [0.07-0.96], p = 0.024). The frequency of the GA
genotype was lower among subjects with DD (2.0%),
Table 1 Candidate gene information
Nr Gene dbSNP
1 Location Allele change References
1 ADIPOQ rs2241766 Exon 2 T/G [51]
2 CILP rs2073711 Exon 8 C/T [34]
3 COL9A2 rs137853213 Exon 19 C/T [10,47]
4 COL9A3 rs61734651 Exon 5 C/T [11]
5 COL11A2 rs1799907 Intron T/A [52,53]
6 COL22A1 rs2292927 Exon 3 C/T -*
7 IL1A rs1800587 Promoter C/T [12,13]
8 IL1B rs1143634 Exon 5 C/T [12]
9 IL1F10 rs3811058 Exon 2 T/C [54]
10 IL6 rs1800797 Promoter G/A [23]
11 IL6 rs1800796 Promoter G/C [23]
12 IL6 rs1800795 Promoter G/C [23]
13 LEPR rs1137100 Exon 4 A/G [55]
14 LEPR rs8179183 Exon 12 G/C [55]
15 MMP9 rs17576 Exon 6 G/A [56]
16 MMP10 rs470154 Intron A/C -*
17 SKT rs16924573 Intron G/A [31]
18 THBS2 rs9406328 Intron T/C [56]
19 VDR rs10735810 Exon 9 T/C [8,57]
1 Names as they appear in NCBI SNP data *Unpublished results.
Table 2 Characteristics of study population at the age of
19
Subjects without DD Subjects with DD
N 246 150
Gender (females, %) 66.3 52.0
Height (mean; cm)
1 167.8 172.3
BMI (mean; kg/m
2)
2 22.6 23.4
1) p = < 0.0001,
2)p = 0.0384
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rs2073711 was associated with DD, but only among
women. The CT/TT genotypes, compared to the CC gen-
otype, resulted in an OR of 2.04 [1.07-3.89], and p = 0.025
(corrected p = 0.05). We did not observe statistically sig-
nificant associations between the other SNPs and DD.
Discussion
Disc degeneration is described as a common multifac-
torial and multigenic condition [3]. At least 14 genes
have been shown to associate with DD, although their
specific effects are notk n o w n .I nt h i ss t u d y ,IL6, SKT
and CILP were associated with moderate DD in a sam-
ple population of young adults who had their MRI taken
at a mean age of 21 years.
IL6 is a pleiotropic cytokine which is expressed in many
cells and is one of the most important mediators of
inflammatory reactions in humans [22]. The role of IL6
and in particular the effect of three common promoter
polymorphisms (rs1800797, rs1800796, rs1800795) has
been studied previously for the presence of sciatica [23],
but also in relation to DD among 12- to 14-year-old chil-
dren [15]. In our population of young adults rs1800797
and rs1800795 were associated with moderate DD. The
G allele of both rs1800797 and rs1800795 was the risk
allele for DD (OR 1.37 [1.02-1.85] and 1.45 [1.07-1.96],
respectively).
T h er o l eo fIL6 was further strengthened with haplo-
type analyses of the promoter SNPs. IL6 haplotype GGG
was associated with moderate DD (OR 1.48 [1.09-2.01]).
In addition, the risk for moderate DD was higher for the
carriers of the GGG/GGG diplotype (OR 2.22 [1.17-
4.22]). This finding is supported by an observation that,
among sciatica patients, GGGA was the risk haplotype
(OR 4.80 [1.59-14.45]) [23]. Furthermore, the GGGA
haplotype was a predisposing factor for future sciatica
symptoms [24]. In a study of young Danish children
Table 3 Genotype frequencies of the analyzed SNPs
Subjects without DD* Subjects with DD*
Gene SNP Minor
allele
11 12 22 11 12 22 OR (95% CI)
ADIPOQ rs2241766 G 94.3 5.7 88.6 11.4 NS
CILP rs2073711 T 31.7 49.8 18.5 24.0 54.0 22.0 NS
COL9A2 rs137853213 T 96.7 3.3 96.0 4.0 NS
COL9A3 rs61734651 T 78.8 20.8 0.4 85.3 14.7 0.0 NS
COL11A2 rs1799907 A 53.2 40.4 6.4 50.7 42.9 6.4 NS
COL22A1 rs2292927 T 59.1 35.2 5.7 59.3 37.0 3.7 NS
IL1A rs1800587 T 43.1 46.3 10.6 42.7 44.7 12.7 NS
IL1B rs1143634 T 57.0 36.9 6.2 54.7 35.3 10.0 NS
IL1F10 rs3811058 C 81.2 17.6 1.2 83.3 16.0 0.7 NS
IL6 rs1800797 G 35.4 47.3 17.3 24.8 52.4 22.8 1.37 [1.02 - 1.85]
1
IL6 rs1800796 C 93.8 6.2 94.0 6.0 NS
IL6 rs1800795 G 36.5 47.5 16.0 25.5 51.0 23.5 1.45 [1.07 - 1.96]
2
LEPR rs1137100 G 39.6 49.8 10.6 48.0 38.7 13.3 NS
LEPR rs8179183 C 78.0 19.2 2.9 80.5 18.8 0.7 NS
MMP9 rs17576 G 37.1 45.7 17.1 37.6 46.3 16.1 NS
MMP10 rs470154 T 90.6 9.4 90.0 7.9 2.1 NS
SKT rs16924573 A 93.4 6.6 98.0 2.0 0.26 [0.07 - 0.96]
3
THBS2 rs9406328 T 52.5 41.8 5.7 59.5 31.8 8.8 NS
VDR rs10735810 T 45.1 48.5 6.4 54.3 37.9 7.9 NS
1) log-additive model, corrected p = 0.074
2) log-additive model, corrected p = 0.042
3) p = 0.023
*Values are expressed as percentages
Table 4 Frequencies of IL6 haplotypes and diplotypes
Subjects
without DD
Subjects with
DD
n % n % OR [95% CI] P-value
AGC 287 59.1 151 50.7 1.00
GGG 177 36.4 136 45.6 1.48 [1.09 - 2.01] 0.0122
GCG 15 3.1 9 3.0 0.88 [0.37 - 2.12]
other 7 1.4 2 0.6 -
AGC/AGC 86 35.0 37 24.7 1.00
GGG/AGC 102 41.5 71 47.3 1.61 [0.97 - 2.67] 0.0650
GGG/GGG 33 13.4 30 20.0 2.22 [1.17 - 4.22] 0.0152
GCG/AGC 10 4.1 5 3.3 1.01 [0.31 - 3.23]
GGG/GCG 5 2.0 4 2.7 1.17 [0.28 - 4.80]
GGC/AGC 3 1.2 1 0.7 0.70 [0.07 - 7.28]
other 7 2.9 2 1.3 -
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ciated with early DD (OR 6.46 [1.61-26]) [15]. This asso-
ciation was present only in females, and the population
with DD was small, consisting of 68 individuals. The
two most common haplotypes observed in that study
were in accordance with the ones we observed in ours
(AGC and GGG), indicating that there are no major dif-
ferences in genotype frequencies between the two study
populations.
Functional analyses have shown that the production
of IL6 is higher in individuals carrying the GG geno-
types for rs1800797 and rs1800795 variations [25]. It
has also been reported that the three common promoter
polymorphisms influence the transcription of IL6 with
the G allele by each being responsible for the increased
overall transcription of IL6 [26]. Overproduction of IL6
has been associated with a spectrum of age-related con-
ditions, including atherosclerosis, peripheral vascular
disease, coronary artery disease, and osteoporosis [27].
It is interesting to note that the same common IL6 pro-
moter variants are also associated with the most severe
forms of distal interphalangeal osteoarthritis [28].
Osteoarthritis and DD share pathological and clinical
features, even though the extent to which the etiological
determinants of these diseases’ processes are similar is
not known [29].
The association of the SKT rs16924573 variant with
DD has not been previously observed. In our popula-
tion, carriers of the minor allele A, which is a rare
allele in the Finnish population, were at a reduced risk
of DD. The importance of SKT in development of cau-
dal intervertebral discs (IVD) in mice has been estab-
lished previously [30]. The mice with homozygotely
trapped SKT gene produce a deformed “kinky tail”
phenotype - seemingly due to nucleus pulposus
changes - during adulthood [30]. These observations
led to the first study with human lumbar disc hernia-
tion patients characterized by sciatica [31]. In the
study an association of SKT rs16924573 G allele with
lumbar disc herniations was found (OR 1.34 [1.14-
1.58]) [31]. DD, phenotype of the present study, is
believed to be an important intermediate stage in
symptomatic disc disease [32], which is often charac-
t e r i z e db yd i s ch e r n i a t i o n seither with or without scia-
tic pain radiating from the back to the leg [33]. Our
current finding is in line with the earlier findings, how-
ever, the differences between the phenotypes in these
studies need to be noted. These findings provide some
support to the hypothesis that SKT could have long-
term importance in the onset of symptomatic disc dis-
e a s eb ym a k i n gt h ed i s c sm o r ev u l n e r a b l ef o rD D .
In addition, an association between the CILP variant
and DD was observed. CILP encodes the cartilage inter-
mediate protein, which inhibits the transforming growth
factor b1- (TGF-b1) mediated induction of extracellular
matrix proteins through direct interaction with TGF-b1
[34]. In the present study, the T allele was associated
with an increased risk of DD. The TT/CT genotype
compared to the CC genotype showed an OR of 2.04
[1.07-3.89]. The association between CILP and DD was,
however, only found in females. This finding is in con-
trast with previously reported associations among Japa-
nese subjects, which indicated the C allele as the risk
allele for symptomatic lumbar disc disease [34] as well
a sf o rl u m b a rD D[ 3 5 , 3 6 ] .H o w e v e r ,ar e p l i c a t i o ns t u d y
in Finnish and Chinese populations did not find an
association between CILP and symptomatic disc disease
o rM R I - d e f i n e dD D[ 3 7 ] .I n t e r e s t i n g l y ,t h eCa l l e l ew a s
associated with reduced risk of knee OA [38], which is
in accordance with our findings that the T allele, and
not the C allele, is the risk allele. Although it was shown
in functional studies that the C allele is responsible for
increased binding and inhibition of TGF-b1 [34], the
discrepancies in the association studies could simply be
due to the difference in allele frequencies between Eur-
opean and Japanese populations http://www.ncbi.nlm.
nih.gov/snp.
In our population, both men and women with DD
were significantly taller than those without DD. The
association between body height and herniated lumbar
disc has previously been contradictory [39,40]. In our
earlier study, height was associated with DD on MRI
among 12- to 14-year-old Danish children (N = 220)
[15]. In another study among middle-aged women living
in the UK (N = 796), individuals with radiographically
defined DD progression over a 9-year period were taller
than individuals without DD progression, but the differ-
ence (0.7 cm) was not statistically significant [41]. How-
ever, in a recent large cohort study (N = 13, 282) body
height recorded at baseline was associated with higher
likelihood of back surgery and low back pain during the
12-year follow-up. Although the associations reached
statistical significance only among males, a similar trend
was observed among females as well [42].
One possible mechanism for the role of body height as
a risk factor is lumbar disc size. Larger discs might be
predisposed to DD due to greater diffusion distances of
nutrients into the centre of the nucleus pulposus [43].
Furthermore, higher discs might be at an increased risk
of mechanical failure under external loading [44].
Finally, facet joint alterations have been found to be
more frequent in taller individuals with lumbar disc her-
niation [45].
To date there have been many reported genetic asso-
ciations in relation to DD, yet only a few have been
replicated in different populations. We were not able to
detect any significant associations for the majority of the
polymorphisms that have been previously implicated in
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definitions of the DD phenotype, sample characteristics,
or true differences in the prevalence of polymorphisms
among ethnic populations. The majority of these studies
have been mainly conducted in adult populations, and
only a few have been performed specifically in younger
populations. It is well possible that a particular gene is
associated with DD at only a particular age; for instance,
a 5A/6A promoter polymorphism of the MMP3 gene
associated with more degenerative findings in the elderly
with a mean age of 73 than in younger subjects with a
mean age of 21.4 [46]. It has also been demonstrated
that the Trp2 allele of COL9A2 is a significant age-
dependent risk factor for the development and severity
of DD, increasing the risk of DD in the 40 to 49 year
age group in the Trp2 carriers [47].
The strength of our study is the young age of the par-
t i c i p a n t so ft h i sp o p u l a t i o n-based birth cohort. The
effects of environmental factors are most likely not so
evident, whereas genetic factors may play a more impor-
tant role in comparison to adult populations. Further-
more, in order to avoid any bias, our genotypes were
defined a priori without any knowledge of the results of
MRI readings. Our DD phenotype was also defined a
priori before the genetic analyses and three specialists
evaluated the MR images independently. Despite the
initial large number of MRI scans, our sample study size
is still fairly modest for studying multifactorial and mul-
tigenic conditions. A further limitation in the study was
that only one SNP was included for the majority of the
genes. For a comprehensive evaluation of the gene, a
more extensive SNP analyses across the gene regions
would be needed.
DD is a common disorder and is believed to be an
important intermediate stage in symptomatic disc dis-
ease [32]. Several recent studies suggest that DD is asso-
ciated with low back symptoms [48-50]. The findings
indicate that a higher degree of lumbar DD is related to
a higher likelihood of symptoms, and the presence of
moderate DD or DD at multiple levels increases the
likelihood of pain [50]. Therefore, the clinical relevance
of genetic studies exploring the pathomechanisms of
DD is indisputable.
Conclusions
In summary, five variations of the 19 selected candidate
SNPs were associated with susceptibility to DD in our
study. Our results support the role of IL6, SKT and
CILP i nD D .F u r t h e r m o r e ,w ew e r ea b l et os h o wt h e
associations in a population of young adults. Overall,
genetic association studies provide information about
specific gene variants on disease occurrence, but inter-
preting their results has proven to be a challenge [29].
T h el a c ko fa s s o c i a t i o no fw e l l - k n o w nv a r i a t i o n s
observed here does not necessarily contradict previous
reporting. Instead our results emphasize the complexity
of DD, and the important role of further studies in
populations with different ethnic and age backgrounds.
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